- Home
- IBRX vs SSL Comparison
IBRX vs SSL Comparison
Compare IBRX & SSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IBRX | SSL |
|---|---|---|
| Founded | 2014 | 1950 |
| Country | United States | South Africa |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 7.4B |
| IPO Year | 2015 | 2002 |
Fundamental Metrics
Financial Performance| Metric | IBRX | SSL |
|---|---|---|
| Price | $8.46 | $13.74 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 7 | 1 |
| Target Price | ★ $12.57 | N/A |
| AVG Volume (30 Days) | ★ 8.4M | 1.6M |
| Earning Date | 05-08-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $113,288,000.00 | N/A |
| Revenue This Year | $88.59 | $3.79 |
| Revenue Next Year | $131.15 | $4.39 |
| P/E Ratio | ★ N/A | $13.51 |
| Revenue Growth | ★ 668.31 | N/A |
| 52 Week Low | $1.95 | $5.24 |
| 52 Week High | $12.43 | $15.18 |
Technical Indicators
Market Signals| Indicator | IBRX | SSL |
|---|---|---|
| Relative Strength Index (RSI) | 57.26 | 57.41 |
| Support Level | $6.68 | $12.04 |
| Resistance Level | $8.51 | $14.37 |
| Average True Range (ATR) | 0.40 | 0.41 |
| MACD | 0.02 | 0.07 |
| Stochastic Oscillator | 68.10 | 56.77 |
Price Performance
Historical ComparisonAbout IBRX ImmunityBio Inc.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
About SSL Sasol Ltd.
Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main businesses: the Southern Africa Energy & Chemicals business and the International Chemical business. It generates maximum revenue from the Southern Africa Energy & Chemicals business, which operates integrated value chains with feedstock sourced from the Mining and Gas operating segments. Geographically, the company generates the majority of its revenue from South Africa.